Se flere resultater
1
Immunogenicity and safety of a booster dose of the COVID-19 DNA vaccine in healthy adults aged 18 years and above: a single-center, randomized, observer-blind, placebo-controlled phase 2 trial
BMC Infectious Diseases
Tilføjet 25.05.2025
2
Safety and Efficacy of Pemivibart, a Long-Acting Monoclonal Antibody, for Prevention of Symptomatic COVID-19: Interim Results From a Phase 3 Randomized Clinical Trial (CANOPY)
Clinical Infectious Diseases
Tilføjet 25.05.2025
3
mRNA COVID-19 vaccines induce superior IgA titers in cancer patients compared to viral vector vaccines: Implications for immunization strategies
International Journal of Infectious Diseases
Tilføjet 24.05.2025
4
Re: ‘Learning from Post COVID-19 condition for epidemic preparedness’ by Gorska et al.
Clinical Microbiology and Infection
Tilføjet 24.05.2025
5
Clinical profile of alcohol dependent paintents according to Lesch Typology one year after the Covid-19 pandemic-comparative study
PLoS One Infectious Diseases
Tilføjet 24.05.2025
6
Cardiac Events in Adults Hospitalized for RSV vs COVID-19 or Influenza
JAMA Network Open New Online
Tilføjet 23.05.2025
7
[Media Watch] COVID-19: the challenges of a digital pandemic
Lancet Infectious Diseases
Tilføjet 23.05.2025
8
2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Vilobelimab
Clinical Infectious Diseases
Tilføjet 23.05.2025
9
Therapeutic options for the treatment of post-acute sequelae of COVID-19: a scoping review
BMC Infectious Diseases
Tilføjet 22.05.2025
10
Development of a risk prediction model for secondary infection in severe/critical COVID-19 patients
BMC Infectious Diseases
Tilføjet 22.05.2025
11
A comprehensive analysis of COVID-19 vaccination behavior: The influence of religion, information sources, political leanings, and demographic factors
PLoS One Infectious Diseases
Tilføjet 22.05.2025
12
An Evidence-Based Approach to Covid-19 Vaccination
New England Journal of Medicine
Tilføjet 21.05.2025
13
Type 2 diabetes mellitus as a predictor of severe outcomes in COVID-19 — a systematic review and meta-analyses
BMC Infectious Diseases
Tilføjet 20.05.2025
14
Target Trial Emulation for Antibiotic Use in Acute COVID-19
JAMA Network Open New Online
Tilføjet 20.05.2025
15
Antibiotic Treatment in Patients Hospitalized for Nonsevere COVID-19
JAMA Network Open New Online
Tilføjet 20.05.2025
16
Longitudinal assessment of COVID-19 vaccine immunogenicity in people with HIV stratified by CD4+ T-cell count in the Netherlands: A two-year follow-up study
PLoS One Infectious Diseases
Tilføjet 20.05.2025
17
Alterations of the gut commensal Akkermansia muciniphila in patients with COVID-19
Virulence
Tilføjet 19.05.2025
18
Tuberculosis mortality and drug resistance among patients under TB treatment before and during COVID-19 in Burundi: a case–control study
BMC Infectious Diseases
Tilføjet 18.05.2025
19
Communication-based interventions to increase COVID-19 vaccine willingness and uptake: a systematic review with meta-analysis
BMJ Open
Tilføjet 16.05.2025
20
[Articles] Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Lancet Infectious Diseases
Tilføjet 16.05.2025